These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 26142830

  • 1. Effect of rovatirelin, a novel thyrotropin-releasing hormone analog, on the central noradrenergic system.
    Ijiro T, Nakamura K, Ogata M, Inada H, Kiguchi S, Maruyama K, Nabekura J, Kobayashi M, Ishibashi H.
    Eur J Pharmacol; 2015 Aug 15; 761():413-22. PubMed ID: 26142830
    [Abstract] [Full Text] [Related]

  • 2. Excitation of locus coeruleus noradrenergic neurons by thyrotropin-releasing hormone.
    Ishibashi H, Nakahata Y, Eto K, Nabekura J.
    J Physiol; 2009 Dec 01; 587(Pt 23):5709-22. PubMed ID: 19840999
    [Abstract] [Full Text] [Related]

  • 3. Rovatirelin ameliorates motor dysfunction in the cytosine arabinoside-induced rat model of spinocerebellar degeneration via acetylcholine and dopamine neurotransmission.
    Ijiro T, Yaguchi A, Yokoyama A, Kiguchi S.
    Clin Exp Pharmacol Physiol; 2022 Sep 01; 49(9):950-958. PubMed ID: 35637550
    [Abstract] [Full Text] [Related]

  • 4. Ameliorating effect of rovatirelin on the ataxia in rolling mouse Nagoya.
    Ijiro T, Yaguchi A, Yokoyama A, Abe Y, Kiguchi S.
    Eur J Pharmacol; 2020 Sep 05; 882():173271. PubMed ID: 32534077
    [Abstract] [Full Text] [Related]

  • 5. Non-clinical pharmacokinetic profiles of rovatirelin, an orally available thyrotropin-releasing hormone analogue.
    Kobayashi K, Abe Y, Harada H, Oota E, Endo T, Takeda H.
    Xenobiotica; 2019 Jan 05; 49(1):106-119. PubMed ID: 29300135
    [Abstract] [Full Text] [Related]

  • 6. Lack of behavioral tolerance by repeated treatment with taltirelin hydrate, a thyrotropin-releasing hormone analog, in rats.
    Asai H, Asahi T, Yamamura M, Yamauchi-Kohno R, Saito A.
    Pharmacol Biochem Behav; 2005 Dec 05; 82(4):646-51. PubMed ID: 16368129
    [Abstract] [Full Text] [Related]

  • 7. Discovery of the Orally Effective Thyrotropin-Releasing Hormone Mimetic: 1-{N-[(4S,5S)-(5-Methyl-2-oxooxazolidine-4-yl)carbonyl]-3-(thiazol-4-yl)-l-alanyl}-(2R)-2-methylpyrrolidine Trihydrate (Rovatirelin Hydrate).
    Kobayashi N, Sato N, Fujimura Y, Kihara T, Sugita K, Takahashi K, Koike K, Sugawara T, Tada Y, Nakai H, Yoshikawa T.
    ACS Omega; 2018 Oct 31; 3(10):13647-13666. PubMed ID: 30411045
    [Abstract] [Full Text] [Related]

  • 8. Chronic citalopram administration desensitizes prefrontal cortex but not somatodendritic α2-adrenoceptors in rat brain.
    Fernández-Pastor B, Ortega JE, Grandoso L, Castro E, Ugedo L, Pazos Á, Meana JJ.
    Neuropharmacology; 2017 Mar 01; 114():114-122. PubMed ID: 27908769
    [Abstract] [Full Text] [Related]

  • 9. [Synthesis and pharmacological action of TRH analog peptide (Taltirelin)].
    Yamamura M, Suzuki M, Matsumoto K.
    Nihon Yakurigaku Zasshi; 1997 Oct 01; 110 Suppl 1():33P-38P. PubMed ID: 9503402
    [Abstract] [Full Text] [Related]

  • 10. Diversity of thyrotropin-releasing hormone receptors in the pituitary and discrete brain regions of rats.
    Asai H, Kinoshita K, Yamamura M, Matsuoka Y.
    Jpn J Pharmacol; 1999 Mar 01; 79(3):313-7. PubMed ID: 10230859
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetic Drug Interactions of an Orally Available TRH Analog (Rovatirelin) With a CYP3A4/5 and P-Glycoprotein Inhibitor (Itraconazole).
    Kobayashi K, Abe Y, Kawai A, Furihata T, Endo T, Takeda H.
    J Clin Pharmacol; 2020 Oct 01; 60(10):1314-1323. PubMed ID: 32459872
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and evaluation of in vivo anti-hypothermic effect of all stereoisomers of the thyrotropin-releasing hormone mimetic: Rovatirelin Hydrate.
    Kobayashi N, Sato N, Sugita K, Takahashi K, Sugawara T, Tada Y, Yoshikawa T.
    J Pept Sci; 2019 Dec 01; 25(12):e3228. PubMed ID: 31713944
    [Abstract] [Full Text] [Related]

  • 13. Chronic fluoxetine reverses the effects of chronic corticosterone treatment on α2-adrenoceptors in the rat frontal cortex but not locus coeruleus.
    Horrillo I, Ortega JE, Diez-Alarcia R, Urigüen L, Meana JJ.
    Neuropharmacology; 2019 Nov 01; 158():107731. PubMed ID: 31376424
    [Abstract] [Full Text] [Related]

  • 14. Effects of taltirelin hydrate (TA-0910), a novel thyrotropin-releasing hormone analog, on in vivo dopamine release and turnover in rat brain.
    Fukuchi I, Asahi T, Kawashima K, Kawashima Y, Yamamura M, Matsuoka Y, Kinoshita K.
    Arzneimittelforschung; 1998 Apr 01; 48(4):353-9. PubMed ID: 9608876
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Noradrenergic lesion of the locus coeruleus increases the firing activity of the medial prefrontal cortex pyramidal neurons and the role of alpha2-adrenoceptors in normal and medial forebrain bundle lesioned rats.
    Wang Y, Zhang QJ, Liu J, Ali U, Gui ZH, Hui YP, Wang T, Chen L, Li Q.
    Brain Res; 2010 Apr 09; 1324():64-74. PubMed ID: 20153300
    [Abstract] [Full Text] [Related]

  • 17. Reversal of hemorrhagic shock in rats using the metabolically stable thyrotropin-releasing hormone analog taltirelin hydrate.
    Asai H, Watanabe Y, Yamauchi-Kohno R, Doi O.
    J Recept Signal Transduct Res; 2011 Dec 09; 31(6):416-22. PubMed ID: 22044177
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Brain receptor binding characteristics and pharmacokinetic-pharmacodynamic analysis of thyrotropin-releasing hormone analogues.
    Urayama A, Yamada S, Hirano K, Deguchi Y, Kimura R.
    Life Sci; 2001 Dec 28; 70(6):647-57. PubMed ID: 11833715
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and Evaluation of in Vivo Anti-hypothermic Effect of the N- and C-Terminus Modified Thyrotropin-Releasing Hormone Mimetic: [(4S,5S)-(5-Methyl-2-oxooxazolidine-4-yl)carbonyl]-[3-(thiazol-4-yl)-L-alanyl]-L-prolinamide.
    Kobayashi N, Sato N, Sugita K, Kihara T, Koike K, Sugawara T, Tada Y, Yoshikawa T.
    Chem Pharm Bull (Tokyo); 2021 Dec 28; 69(4):314-324. PubMed ID: 33790077
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.